Comparison of oxygen consumption, energy expenditure, and respiratory exchange ratio (RER) between resmetirom and semaglutide Activation of THR- in the liver affects fatty acid metabolism and improves hepatic fat content
Julie Cunningham, MPH, RDN, LDN, CDCES Medical Reviewer Julie Cunningham is a registered dietitian-nutritionist and a certified diabetes care and education specialist
We handle prior authorizations for you and offer skilled medical guidance to ensure every member uses GLP1s safely and effectively
Another condition that commonly co-exists with type 2 diabetes and significantly increases the risk of cardiovascular disease is non-alcoholic fatty liver disease (NAFLD), more recently termed metabolic dysfunction-associated steatotic liver disease (MASLD)
Knowing which drugs carry the weight-loss indication matters because it affects insurance coverage, manufacturer savings card eligibility, and which treatment plan your healthcare provider can prescribe